Antisynthetase Syndrome: A Review of Etiopathogenesis, Diagnosis and Management

Author(s): Aibek E. Mirrakhimov

Journal Name: Current Medicinal Chemistry

Volume 22 , Issue 16 , 2015

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer


Antisynthetase syndrome is a group of closely related rare diseases which clinically manifest with inflammatory myopathies, interstitial lung disease, inflammatory arthritis, skin hyperkeratosis (mechanic’s hands) and Raynaud phenomenon. The pathophysiology of antisynthetase syndrome is not entirely understood, but genetic predisposition, viral infections and medication use may play a role. Certain antisynthetase antibodies are associated with various clinical presentations and a lower burden of inflammatory myopathies. Patients with antisynthetase syndrome have a worse prognosis than patients with pure inflammatory myopathies mainly because of interstitial lung disease. Future research should further investigate the pathogenesis of antisynthetase syndrome which could identify new therapeutic targets. It will be also important to study whether patients with AS are at increased risk of cancer and whether certain antisynthetase antibodies have any association with the risk of malignancy.

Keywords: Antisynthetase antibodies, antisynthetase syndrome, autoimmunity, cancer, glucocorticoids, inflammatory myopathy, interstitial lung disease, Raynaud phenomenon.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Published on: 14 May, 2015
Page: [1963 - 1975]
Pages: 13
DOI: 10.2174/0929867322666150514094935
Price: $65

Article Metrics

PDF: 153
HTML: 13
PRC: 3